135 related articles for article (PubMed ID: 32243305)
1. An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Schiffman M; Wentzensen N; Perkins RB; Guido RS
J Low Genit Tract Dis; 2020 Apr; 24(2):87-89. PubMed ID: 32243305
[No Abstract] [Full Text] [Related]
2. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB; Guido RS; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M;
J Low Genit Tract Dis; 2020 Apr; 24(2):102-131. PubMed ID: 32243307
[No Abstract] [Full Text] [Related]
3. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
4. Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Egemen D; Cheung LC; Chen X; Demarco M; Perkins RB; Kinney W; Poitras N; Befano B; Locke A; Guido RS; Wiser AL; Gage JC; Katki HA; Wentzensen N; Castle PE; Schiffman M; Lorey TS
J Low Genit Tract Dis; 2020 Apr; 24(2):132-143. PubMed ID: 32243308
[TBL] [Abstract][Full Text] [Related]
5. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
Fontaine PL; Saslow D; King VJ
Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
[No Abstract] [Full Text] [Related]
6. Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines.
Schiffman M; Wentzensen N; Khan MJ; Castle PE; Chelmow D; Huh WK; Moscicki AB; Stockdale CK; Darragh TM; Silver M; Guido RS
J Low Genit Tract Dis; 2017 Apr; 21(2):87-90. PubMed ID: 28244885
[No Abstract] [Full Text] [Related]
7. 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.
Cheung LC; Egemen D; Chen X; Katki HA; Demarco M; Wiser AL; Perkins RB; Guido RS; Wentzensen N; Schiffman M
J Low Genit Tract Dis; 2020 Apr; 24(2):90-101. PubMed ID: 32243306
[TBL] [Abstract][Full Text] [Related]
8. Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB; Guido RL; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya G; Wentzensen N; Schiffman M
J Low Genit Tract Dis; 2020 Oct; 24(4):426. PubMed ID: 32732648
[No Abstract] [Full Text] [Related]
9. Trial quickly changed management of cervical abnormalities.
Zielinski SL
J Natl Cancer Inst; 2005 Apr; 97(7):479-80. PubMed ID: 15812071
[No Abstract] [Full Text] [Related]
10. Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005.
Benard VB; Howe W; Saraiya M; Helsel W; Lawson HW
J Low Genit Tract Dis; 2008 Oct; 12(4):300-6. PubMed ID: 18820545
[TBL] [Abstract][Full Text] [Related]
11. Management of abnormal pap smear--consensus guidelines of the National Cervical Cancer Screening Programme in Poland Coordinating Centre, the Polish Gynaecological Society, the Polish Society of Pathologists, and Polish Society of Colposcopy and Uterine Cervix Pathology.
; ; ;
Ginekol Pol; 2009 Feb; 80(2):129-38. PubMed ID: 19338211
[No Abstract] [Full Text] [Related]
12. Procedural and temporal compliance to cervical cancer screening guidelines in a CDC-funded program in Alaska.
Anderson KJ; Speranza PD
J Low Genit Tract Dis; 2011 Apr; 15(2):98-104. PubMed ID: 21169865
[TBL] [Abstract][Full Text] [Related]
13. Ushering in a new era: human papillomavirus (HPV) testing comes to the NHS Cervical Screening Programme.
Szarewski A
J Fam Plann Reprod Health Care; 2011 Apr; 37(2):64-7. PubMed ID: 21454257
[No Abstract] [Full Text] [Related]
14. A Question to the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Fu Y; Wang X; Lü W
J Low Genit Tract Dis; 2020 Oct; 24(4):425. PubMed ID: 32796263
[No Abstract] [Full Text] [Related]
15. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
Printz C
Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
[No Abstract] [Full Text] [Related]
16. Human Papillomavirus Testing by Veterans Administration Women's Health Providers: Are They Adhering to Guidelines?
Hallett LD; Gerber MR
J Womens Health (Larchmt); 2018 Feb; 27(2):179-182. PubMed ID: 28885082
[TBL] [Abstract][Full Text] [Related]
17. Making sense of the new cervical-cancer screening guidelines.
Feldman S
N Engl J Med; 2011 Dec; 365(23):2145-7. PubMed ID: 22111669
[No Abstract] [Full Text] [Related]
18. The New ASCCP Colposcopy Standards.
Wright TC
J Low Genit Tract Dis; 2017 Oct; 21(4):215. PubMed ID: 28953108
[No Abstract] [Full Text] [Related]
19. Cervical cancer screening.
Burns R
Cleve Clin J Med; 2005 Apr; 72(4):272; author reply 272. PubMed ID: 15850238
[No Abstract] [Full Text] [Related]
20. Revised screening guidelines reviewed.
AIDS Patient Care STDS; 2003 Oct; 17(10):544. PubMed ID: 14608976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
